Trade Mark Journal No.2021/053 31 December 2021

WO0000001630319 (5,42)

Office of origin: United States of America

Date of International Registration:22 September 2021
Date of designation in the UK: 22 September 2021
Image for mark 1630319 RNAFIX

Class 5
Pharmaceutical preparations for the treatment of genetic disorders.
Class 42
Product development in the field of identifying genetic therapy; research and development of technology in the field of genetic therapy; scientific research for medical purposes in the field of genetic therapy.

Shape Therapeutics Inc.

Representative: Michael A. Geller DLA Piper LLP (US), P.O. Box 64807, Chicago IL 60664-0807, UNITED STATES OF AMERICA